96,95 €
96,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
48 °P sammeln
96,95 €
96,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
48 °P sammeln
Als Download kaufen
96,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
48 °P sammeln
Jetzt verschenken
96,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
48 °P sammeln
  • Format: ePub

Vaccinology and Methods in Vaccine Research is a combination of cutting-edge methodologies, experimental approaches and literature reviews. The book covers all aspects of vaccine development, including basic immunology (focusing on the stimulation of adaptive immunity, which is required for vaccine efficacy), approaches to vaccine design and target validation, vaccine biomanufacturer and clinical development. Existing vaccinology resources are theoretical reference books, whereas this book provides a practical handbook for use in the research lab and classroom by those working in vaccinology…mehr

Produktbeschreibung
Vaccinology and Methods in Vaccine Research is a combination of cutting-edge methodologies, experimental approaches and literature reviews. The book covers all aspects of vaccine development, including basic immunology (focusing on the stimulation of adaptive immunity, which is required for vaccine efficacy), approaches to vaccine design and target validation, vaccine biomanufacturer and clinical development. Existing vaccinology resources are theoretical reference books, whereas this book provides a practical handbook for use in the research lab and classroom by those working in vaccinology and training others in the field.

It is authored and edited by scientists actively engaged in vaccine research and development for day-to-day teaching/methodological advice.

  • Addresses how to design a vaccine for an emerging disease, from a practical point-of -view, with chapters written by scientists who are grappling with these questions
  • Provides new approaches to vaccine development. including vaccine targeting and virus-like-particle vaccines
  • Gives up-to-date information and methodologies in use for vaccine adjuvants

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Rebecca Ashfield Jenner Institute, University of Oxford (ORCRB Roosevelt Drive Oxford OX3 7DQ). BA (1st class) Oxford, DPhil Oxford, over 20 years working in field of immunotherapy and vaccine development. Currently CSO of Ducentis Biotherapeutics Ltd and Senior Project Manager at the Jenner Institute. Organiser/co-leader of several vaccinology courses in Oxford and Leiden. Edited most recent Jenner Institute triennial report. Expertise in vaccine GMP manufacture, led successful application to Innovate UK for £75M vaccine innovation and manufacturing centre, currently being built at Harwell in Oxfordshire. H=20Angus Nnamdi Oli Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University (NAU), Agulu Campus (Post code 422001, Agulu, Anambra State, Nigeria). BPharm. and MPharm. UNN, DPhil NAU and a DPharm. University of Benin, Nigeria. Currently a Senior Lecturer with over 8 years' experience. Author of several articles in peer-reviewed journals indexed in Pubmed, Web of Science and Scopus. Current research interests/career goals are Infection and immunology of infectious diseases with emphasis of viral and bacterial infections, development of effective vaccines with strong antibody and T lymphocytes effect or responses against the infections, Pharmaceutical Quality Systems and Clinical vaccinology. H: 5